BANK OF AMERICA CORP /DE/ - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$68,454,000
+116.8%
452,832
+108.9%
0.01%
+100.0%
Q2 2022$31,578,000
-15.0%
216,718
-30.8%
0.00%0.0%
Q1 2022$37,145,000
-2.1%
313,275
+13.8%
0.00%0.0%
Q4 2021$37,947,000
+11.7%
275,361
+12.6%
0.00%0.0%
Q3 2021$33,969,000
+46.8%
244,537
+2.6%
0.00%
+100.0%
Q2 2021$23,142,000
+65.1%
238,378
+16.2%
0.00%0.0%
Q1 2021$14,018,000
+12.4%
205,100
+41.0%
0.00%0.0%
Q4 2020$12,472,000
+72.0%
145,505
+30.5%
0.00%
+100.0%
Q3 2020$7,251,000
-12.0%
111,526
-1.0%
0.00%0.0%
Q2 2020$8,239,000
+117.0%
112,685
+1.0%
0.00%0.0%
Q1 2020$3,796,000
-45.2%
111,529
-12.3%
0.00%0.0%
Q4 2019$6,921,000
-49.2%
127,135
-61.1%
0.00%0.0%
Q3 2019$13,635,000
-13.4%
326,818
-9.1%
0.00%
-50.0%
Q2 2019$15,741,000
+38.6%
359,448
+62.9%
0.00%
+100.0%
Q1 2019$11,357,000
+229.1%
220,641
+136.4%
0.00%0.0%
Q4 2018$3,451,000
+12.0%
93,317
+13.7%
0.00%
Q3 2018$3,081,000
-39.3%
82,049
-36.1%
0.00%
-100.0%
Q2 2018$5,073,000
+106.9%
128,367
+34.9%
0.00%
Q1 2018$2,452,000
+16.8%
95,152
+22.3%
0.00%
Q4 2017$2,100,000
-63.4%
77,819
-49.3%
0.00%
-100.0%
Q3 2017$5,733,000
+133.2%
153,370
+56.0%
0.00%
Q2 2017$2,458,00098,3180.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders